Syphilis among men who have sex with men (MSM) in Taiwan: its association with HIV prevalence, awareness of HIV status, and use of antiretroviral therapy

AIDS Behav. 2013 May;17(4):1406-14. doi: 10.1007/s10461-012-0405-9.

Abstract

To understand how awareness of HIV-positivity and the use of antiretroviral therapy associated with syphilis infection, 361 MSM attending 16 Hong-Pa (drug-and-sex parties) in Taiwan were studied. The syphilis rate of individuals within their first 2 years after HIV diagnosis (awareness) was lower than that in individuals who had not been diagnosed HIV infection prior to Hong-Pa (unawareness) (Adj OR = 0.24, P < 0.05). Notably, there was a decrease in the beneficial effect of HIV-positive status awareness on syphilis prevention with an increase in time since notification. Moreover, antiretroviral therapy was not associated with a lower incidence of syphilis, and syphilis infection peaked during the treatment dropout period. In conclusion, the duration of a protective effect of knowing one's HIV-positivity against syphilis infection was short, and the highest risk of syphilis infection was observed when patients discontinued antiretroviral therapy. Future research should examine the behavioral mechanisms involved in this prevention failure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Retroviral Agents / adverse effects
  • Anti-Retroviral Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Cross-Sectional Studies
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology*
  • HIV Seropositivity
  • Health Knowledge, Attitudes, Practice
  • Homosexuality, Male / statistics & numerical data*
  • Humans
  • Incidence
  • Logistic Models
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • Risk Reduction Behavior
  • Risk-Taking
  • Sexual Behavior / statistics & numerical data*
  • Surveys and Questionnaires
  • Syphilis / diagnosis*
  • Syphilis / epidemiology
  • Taiwan / epidemiology

Substances

  • Anti-Retroviral Agents